Cullinan Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGEM research report →
Companycullinantherapeutics.com
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
- CEO
- Nadim Ahmed
- IPO
- 2021
- Employees
- 111
- HQ
- Cambridge, MA, US
Price Chart
Valuation
- Market Cap
- $880.69M
- P/E
- -3.84
- P/S
- 0.00
- P/B
- 2.32
- EV/EBITDA
- -3.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -51.45%
- ROIC
- -65.21%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-219,879,000 · -31.36%
- EPS
- $-3.72 · -19.61%
- Op Income
- $-241,648,000
- FCF YoY
- -20.99%
Performance & Tape
- 52W High
- $16.74
- 52W Low
- $5.68
- 50D MA
- $14.22
- 200D MA
- $10.71
- Beta
- -0.09
- Avg Volume
- 869.69K
Get TickerSpark's AI analysis on CGEM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 5, 26 | Michaelson Jennifer | other | 4,000 |
| May 5, 26 | Michaelson Jennifer | sell | 7,800 |
| May 5, 26 | Michaelson Jennifer | sell | 200 |
| May 5, 26 | Michaelson Jennifer | other | 4,000 |
| Mar 5, 26 | Michaelson Jennifer | other | 4,000 |
| Mar 5, 26 | Michaelson Jennifer | sell | 8,000 |
| Mar 5, 26 | Michaelson Jennifer | other | 4,000 |
| Feb 25, 26 | Michaelson Jennifer | sell | 1,780 |
| Feb 23, 26 | Michaelson Jennifer | sell | 1,752 |
| Feb 24, 26 | Michaelson Jennifer | sell | 3,601 |
Our CGEM Coverage
We haven't published any research on CGEM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CGEM Report →